QWM
BIIB icon

Quaker Wealth Management’s Biogen BIIB Stock Holding History

Quaker Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$548 – 958
2025
Q1 		$548 Buy
+4
New +$572 ﹤0.01% 619

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Quaker Wealth Management's BIIB Position: Q2 2026 in Review

Quaker Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 6 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #529.

Quaker Wealth Management first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Quaker Wealth Management held 6 shares of Biogen worth $1.3K as of Q2 2026.
  • Quaker Wealth Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #529 holding.
  • Quaker Wealth Management first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
  • 362 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.